Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neonatology
  Free Subscription

Articles published in
Pediatr Pulmonol
    October 2025
  1. ZHAO T, An N, Zhu Y, Yang J, et al
    Dynamic Risk-Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants.
    Pediatr Pulmonol. 2025;60:e71322.
    >> Share

  2. DURRANI NUR, Mohammed MBI, Cyprian FS, Khan MN, et al
    Antenatal Late Preterm Infants Exposure to Steroids (ALPINES) and Risk of Respiratory Distress and Hypoglycemia: A Retrospective Chart Review.
    Pediatr Pulmonol. 2025;60:e71336.
    >> Share

  3. DIFIGLIA S, Georgiopoulos AM, Seng EK, Portenoy R, et al
    Illness Burden in Adults With Cystic Fibrosis: Associations With Sex, Race/Ethnicity, and Socioeconomic Risk Factors.
    Pediatr Pulmonol. 2025;60:e71306.
    >> Share

  4. RUB DM, Napolitano N, Simmons F, Mackenzie R, et al
    Evaluating Clinically Directed Continuous Positive Airway Pressure to High Flow Nasal Cannula Transitions in Stable Preterm Infants Using Electrical Impedance Tomography: A Prospective, Observational Study.
    Pediatr Pulmonol. 2025;60:e71328.
    >> Share

  5. ZOU Z, Fu L, Liu J, He Y, et al
    Identification and Validation of TFF3 as a Diagnostic Biomarker and Therapeutic Agent for Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71320.
    >> Share

  6. MOSQUERA RA, Yadav A, Romero-Lopez MDM, Magana-Ceballos IG, et al
    The Effect of Chronic Azithromycin Use in Winter on Health Care Utilization for Children With Bronchopulmonary Dysplasia: A Double Blind Randomized Controlled Study (RCT).
    Pediatr Pulmonol. 2025;60:e71314.
    >> Share

  7. FLEURY M, Delestrain C, Hadchouel A, Mazenq J, et al
    Phenotype-Genotype Correlations in ABCA3 Patients-The RespiRare Cohort.
    Pediatr Pulmonol. 2025;60:e71324.
    >> Share

  8. TERVO JP, Moore BM, DiMango E, Sadeghi H, et al
    Domain-Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71348.
    >> Share

  9. ZAMPOLI M, Baird C, Morrow B, Verstraete J, et al
    Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality.
    Pediatr Pulmonol. 2025;60:e71338.
    >> Share

  10. SAITO T, Shimokaze T, Inagaki Y, Noguchi T, et al
    Impact of Neurally Adjusted Ventilatory Assist Management on Neurodevelopmental Outcomes in Extremely Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71327.
    >> Share

  11. NAKAZAWA Y, Ueda K, Tanahashi Y, Aoki T, et al
    Exhaled Carbon Dioxide Monitoring Using Instantaneous CO(2) Mode During High-Frequency Oscillatory Ventilation in Very Low Birth Weight Infants.
    Pediatr Pulmonol. 2025;60:e71323.
    >> Share

  12. PRABHAKAR N, Sri G, Bhatia A, Sodhi KS, et al
    Scimitar Syndrome: A Rare Congenital Conundrum in a Child With Stridor.
    Pediatr Pulmonol. 2025;60:e71268.
    >> Share

  13. KUGELMAN A
    Can We Enhance Long Term Respiratory Outcomes of Neonatal Pulmonary Diseases?
    Pediatr Pulmonol. 2025;60:e71341.
    >> Share

  14. TSVIBAN L, Amitai N, Levine H, Jacobi E, et al
    Vaccine Coverage Among People With Cystic Fibrosis: A National Multicenter Cross-Sectional Study in Israel.
    Pediatr Pulmonol. 2025;60:e71343.
    >> Share

  15. ALI HA, Baiome NS, Salem YA
    Development of a Simplified Arabic Questionnaire of Health-Related Quality of Life for Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71332.
    >> Share

  16. MAWLANA W, Elhady M, Alhoweiti A, Osman A, et al
    Lung Ultrasound Score as a Predictor for Extubation Failure in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71352.
    >> Share

  17. DUYGULU BULAN D, Dayanan R, Kahraman NC, Kunt S, et al
    Pulmonary Vascular Doppler and Fetal Lung Biometry as Predictors of Neonatal Respiratory Complications in Early- and Late-Onset Fetal Growth Restriction.
    Pediatr Pulmonol. 2025;60:e71333.
    >> Share

  18. SHUGG T, Gallaway KA, Powell N, Skaar TC, et al
    Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk.
    Pediatr Pulmonol. 2025;60:e71360.
    >> Share

  19. SAYEDI SJ, Kheirabadi T, Zibaee S, Bakhtiari E, et al
    Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial.
    Pediatr Pulmonol. 2025;60:e71298.
    >> Share

  20. LEE JX, Ryan ME, Sun BZ, Beam K, et al
    Predictors of Bronchodilator Response on Oscillometry and Spirometry in School-Age Children With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71359.
    >> Share

  21. KUMAR J, Pai K, Raghav A, Meena J, et al
    Efficacy and Safety of T-Piece Resuscitators Versus Self-Inflating Bags for Neonatal Resuscitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pediatr Pulmonol. 2025;60:e71354.
    >> Share

  22. TANG X, Chen Q, Liu Q, Chen M, et al
    Prenatal Exposure to Perfluorooctanoic Acid and Childhood Allergic Diseases: A Prospective Birth Cohort Study.
    Pediatr Pulmonol. 2025;60:e71191.
    >> Share

  23. GUAN Y, Wen X, Zhang X, Xu Z, et al
    Novel Pulmonary Manifestations in Pediatric Late-Onset Congenital Central Hypoventilation Syndrome: A Case Series of PHOX2B-Associated Pulmonary Hypertension and Pulmonary Alveolar Hemorrhage.
    Pediatr Pulmonol. 2025;60:e71347.
    >> Share

    September 2025
  24. GARCIA-GOZALO M, Pellicer A, Bravo MC
    Current Practices for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain.
    Pediatr Pulmonol. 2025;60:e71259.
    >> Share

  25. ALOTAIBI NZ, Lein DH, Yuen HK, Harris RA, et al
    Survey Validation of Exercise and Body Composition Testing and Exercise Training Programs for People With Cystic Fibrosis: A Delphi Study.
    Pediatr Pulmonol. 2025;60:e71262.
    >> Share

  26. TROST SU, Harindhanavudhi T, Wang Q, Ankireddypalli A, et al
    Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis.
    Pediatr Pulmonol. 2025;60:e71280.
    >> Share

  27. SOMBATTINA V, Nangia S, Kumar G, Bandyopadhyay T, et al
    Early (/= 37 Weeks) Neonates With Meconium Aspiration Syndrome: An Open-Label Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e71292.
    >> Share

  28. CARLIN D, Martin A, VanCliff C, Baldwin N, et al
    Caregiver Social Needs and Outpatient Respiratory Outcomes in a Cohort of Children With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71286.
    >> Share

  29. ZAMAL A, Sk MH, Saha B, Hazra A, et al
    Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants(28(+0) to 34(+6) Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e71281.
    >> Share

  30. HOUSE M, Rowe J, Walters A, Liu C, et al
    Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71275.
    >> Share

  31. DOLEZALOVA K, Kodetova J, Klabusayova E, Svobodova J, et al
    Beyond the Usual Suspects: Neonatal Fever and Desaturation.
    Pediatr Pulmonol. 2025;60:e71291.
    >> Share

  32. TSOI SM, Karvonen KL, Steurer MA, Keller RL, et al
    The Impact of Race and Ethnicity on Congenital Diaphragmatic Hernia 1-Year Mortality.
    Pediatr Pulmonol. 2025;60:e71294.
    >> Share

  33. GIPSMAN AI, Blanke MN, Oliver ER, Hedrick HL, et al
    Congenital Diaphragmatic Hernia Patch Infection Presenting With Digital Clubbing.
    Pediatr Pulmonol. 2025;60:e71263.
    >> Share

  34. MURRAY LP, Zamani M, Cogen JD, Hall M, et al
    Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid.
    Pediatr Pulmonol. 2025;60:e71302.
    >> Share

  35. HOPPE JE, Vigers T, Trujillo A, Hanley E, et al
    Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71289.
    >> Share

  36. WANG X, Tang Z, Wang Z
    Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021.
    Pediatr Pulmonol. 2025;60:e71277.
    >> Share

  37. ZANNIN E, Rigotti C, Dognini G, Azzolina D, et al
    Impact of Duration of Nasal High Flow Therapy on Respiratory Outcomes in Very Preterm Infants: A Propensity Score Analysis.
    Pediatr Pulmonol. 2025;60:e71313.
    >> Share

  38. WANG K, Dan C, Gao S, Guang Y, et al
    Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-Analysis.
    Pediatr Pulmonol. 2025;60:e71308.
    >> Share

  39. ITO M, Ohfuji S, Terui K, Nagata K, et al
    An Optimal Initial Ventilation Mode in Congenital Diaphragmatic Hernia: A Prospective Cohort Study.
    Pediatr Pulmonol. 2025;60:e71316.
    >> Share

  40. COTE A, Savanh P, Shalish W, Bizgu V, et al
    Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease.
    Pediatr Pulmonol. 2025;60:e71312.
    >> Share

  41. ROLLO G, Zarfati A, Burini G, Valfre L, et al
    Persistent Low-Output Neonatal Chylothorax: How Long Are We Justified to Wait for Pleurodesis in Partial Responders?
    Pediatr Pulmonol. 2025;60:e71311.
    >> Share

    August 2025
  42. OATES GR, Riekert KA, Ford C, Dickinson KM, et al
    Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71230.
    >> Share

  43. TILLMAN EM, McKinzie C, Young D, Kam C, et al
    Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71229.
    >> Share

  44. SANCHEZ-SOLANO NJ, Wall TJ, Barton GP, Dane DM, et al
    Lung Function in a Multiethnic U.S. Cohort of Adolescents and Adults Born Preterm in the New BPD Era.
    Pediatr Pulmonol. 2025;60:e71226.
    >> Share

  45. PETTIT RS, Howell K, Langhorst J, Flora CC, et al
    Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71231.
    >> Share

  46. SAVANT AP
    Cystic Fibrosis Year in Review 2024.
    Pediatr Pulmonol. 2025;60:e71222.
    >> Share

  47. DUDOIGNON B, Abdelkarim R, Delclaux C, Bokov P, et al
    Is Positive Airway Pressure Lab-Titration Always Necessary to Start Noninvasive Respiratory Support in Infants?
    Pediatr Pulmonol. 2025;60:e71233.
    >> Share

  48. POGGI C, Fusco M, Sassudelli G, Corsini I, et al
    Prediction of Bronchopulmonary Dysplasia by Diaphragmatic Ultrasound in Preterm Infants: A Prospective Pilot Study.
    Pediatr Pulmonol. 2025;60:e71243.
    >> Share

  49. CHOTZOGLOU E, Prasath A, Desai R, David L, et al
    Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in >/= 35 Weeks Gestational Age Infants.
    Pediatr Pulmonol. 2025;60:e71257.
    >> Share

  50. ANDINA MARTINEZ D, Claret Teruel G, Gijon Mediavilla M, Fernandez Mozo E, et al
    Nirsevimab and Acute Bronchiolitis Admissions in Infants Under One Year of Age.
    Pediatr Pulmonol. 2025;60:e71249.
    >> Share

  51. YANG K, Sun W, Wang B
    Crystal Ball or Compass? Navigating the Clinical Use of Predictive Models in Neonatal Care.
    Pediatr Pulmonol. 2025;60:e71248.
    >> Share

  52. GUENTHER CS, Chiel LE, Dy FJ, Lee EY, et al
    Thinking Fast: Addressing a Tachypneic Infant.
    Pediatr Pulmonol. 2025;60:e71238.
    >> Share

  53. ANNE-MARIE DP, Leah G, Nyathi NM, Stephanie GR, et al
    Correlation of High Resolution CT Findings With Lung Function in Adolescents With Perinatally Acquired HIV on Anti-Retroviral Therapy.
    Pediatr Pulmonol. 2025;60:e71234.
    >> Share

  54. CARTY L, Dobra R, Francis J, Puckey M, et al
    Qualitative Experiences and Depression/Anxiety Scores in Parents of Children With Cystic Fibrosis Transmembrane Conductance Regulator Related Metabolic Syndrome.
    Pediatr Pulmonol. 2025;60:e71224.
    >> Share

  55. HOLCIK S, Hawayi L, Dussah N, Barrowman N, et al
    Risk Factors for Severe Respiratory Morbidity at 2 Years of Life in Children Born Extremely Preterm With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71258.
    >> Share

  56. YUCE OZDEMIR H, Mumusoglu S, Kalyoncu AF, Damadoglu E, et al
    Knowledge, Attitudes, and Behaviors of Cystic Fibrosis Patients on Reproductive Health in Turkiye.
    Pediatr Pulmonol. 2025;60:e71247.
    >> Share

  57. DIPPEL CM, Sohrabi K, Takoulegha D, Ehrhardt H, et al
    Effects of Short Versus Prolonged Inspiratory Times on Oxygen Saturation Targeting in Very Low Birth Weight Infants During Synchronized NIPPV.
    Pediatr Pulmonol. 2025;60:e71250.
    >> Share

  58. SAITO T, Maruyama Y, Miyosawa Y, Hirabayashi K, et al
    Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV-NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis.
    Pediatr Pulmonol. 2025;60:e71246.
    >> Share

  59. AZAM A, Barry PJ, Bright-Thomas RJ, Horsley A, et al
    The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71266.
    >> Share

  60. YILDIZ CA, Selcuk Balci M, Kocakaya D, Cinar C, et al
    Healthy Homes, Healthy Lungs: The Role of Home Insulation in Environmental Impact on People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71253.
    >> Share

  61. MOORE CE, Chen W, Bichl S, Wong A, et al
    Utility of Continuous Glucose Monitors for Improved Detection of Cystic Fibrosis-Related Diabetes.
    Pediatr Pulmonol. 2025;60:e71267.
    >> Share

  62. BRUMER E, Shabanova V, Urbach H, Montgomery A, et al
    Bronchopulmonary Dysplasia in the First Year: Insights Into Severity, Medication Use, and Healthcare Utilization.
    Pediatr Pulmonol. 2025;60:e71254.
    >> Share

    July 2025
  63. SCHOOP AC, Denz R, Maier C, Brinkmann F, et al
    Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e71189.
    >> Share

  64. YASUI M, Ogihara T, Yamaoka S, Shinohara J, et al
    The Reference Interval for the Attainment of Comparable Term Functional Levels of Pulmonary Oxygenation Capacity in Healthy Preterm Infants: A Single-Center Retrospective Study.
    Pediatr Pulmonol. 2025;60:e71182.
    >> Share

  65. NENNA R, Petrarca L, Conti MG, Mancino E, et al
    Blood Neutrophils in Infants Admitted for Bronchiolitis and Subsequent Lung Function Impairment.
    Pediatr Pulmonol. 2025;60:e71058.
    >> Share

  66. ZANNIN E, Rigotti C, Robbiani S, Dellaca RL, et al
    Temperature and Humidity During Different Neonatal Respiratory Support Modes: An In-Vitro Performance of Four Heated Humidifiers.
    Pediatr Pulmonol. 2025;60:e71184.
    >> Share

  67. HORNE RSC, Yee AK, Siriwardhana LS, Walter LM, et al
    Long Term Developmental Consequences of Short Apneas and Periodic Breathing in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71193.
    >> Share

  68. LOZANO-RAY E, Argent AC, Lupton-Smith A, Morrow BM, et al
    The Effect of Limiting Anterior Chest Wall Movement With a Weighted Blanket on Comfort, Oxygenation, and Ventilation Homogeneity in Nonventilated Infants and Children Admitted to Hospital With Lower Respiratory Tract Infections: An Exploratory Pilot S
    Pediatr Pulmonol. 2025;60:e71186.
    >> Share

  69. CHOUROU H, Ben Aziza R, Bourcheda M, Sdiri Y, et al
    Congenital Pulmonary Airway Malformations: Experience of a Tunisian Tertiary Referral Center Over a Five-Year Period.
    Pediatr Pulmonol. 2025;60:e71188.
    >> Share

  70. KARTAL OZTURK G, Halis E, Ocak E, Eski A, et al
    Exploring Bone Health in Cystic Fibrosis: A Study From a Lung Transplantation Center and Strategy for Clinical Care.
    Pediatr Pulmonol. 2025;60:e71210.
    >> Share

  71. CHEMALI D, Fleischer E, Uyeno R, Mullowney T, et al
    Variations in the Management of Canadian Patients With CFTR Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID).
    Pediatr Pulmonol. 2025;60:e71200.
    >> Share

  72. RAIMONDI F, Dolce P, Veropalumbo C, Sierchio E, et al
    A Simplified, Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS: A Prospective Observational Study.
    Pediatr Pulmonol. 2025;60:e71206.
    >> Share

  73. ERNEST TE, Ozalvo D, Staretz-Chacham O, Marks KA, et al
    Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71201.
    >> Share

  74. HERGENROEDER GE, Psoter KJ, Brown CD, Ostrenga J, et al
    Baseline Characteristics and Self-Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO-2) Cohort.
    Pediatr Pulmonol. 2025;60:e71190.
    >> Share

  75. PASTEKA R, Hufnagl L, Vodenicharov V, Blessing A, et al
    Surfactant Delivery Is Crucial for Enhancing Function of Ex-Vivo Premature Sheep Lungs: A Feasibility Study.
    Pediatr Pulmonol. 2025;60:e71205.
    >> Share

  76. LONABAUGH KP, Saulitis A, Boettinger E, Brighton D, et al
    Improving Modulator Management and Side Effect Screening: A CF Learning Network Innovation Lab.
    Pediatr Pulmonol. 2025;60:e71187.
    >> Share

  77. SMITH JS, Coffey MJ, Jaffe A, Chuang S, et al
    Disorders of Gut-Brain Interaction in a Pediatric Cystic Fibrosis Cohort.
    Pediatr Pulmonol. 2025;60:e71214.
    >> Share

  78. KUMAR P, Goyal JP, Bhat JI, Dhochak N, et al
    Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study.
    Pediatr Pulmonol. 2025;60:e71194.
    >> Share

  79. RODRIGUEZ-MARTINEZ CE, Midulla F, Nino G
    Viral Bronchiolitis in Infants in the Era of Targeted Therapies: What Now and What's Next?
    Pediatr Pulmonol. 2025;60:e71215.
    >> Share

  80. LIU TW, Huang SY, Chou CM, Lin CH, et al
    The Association Between the Surgical Timing for Congenital Malformation of Lung and Asthma Prevalence-A Nationwide Cohort Study.
    Pediatr Pulmonol. 2025;60:e71225.
    >> Share

  81. GATES Q, Ehwerhemuepha L, Janardhan S, Joshi R, et al
    Early Prediction of Mechanical Ventilation Needs in Very Preterm Neonates Using Machine Learning.
    Pediatr Pulmonol. 2025;60:e71195.
    >> Share

    June 2025
  82. SINGH R, Ojha V, Faisal NV, Kumar S, et al
    Innominate Artery Compression Syndrome in an Infant With Acyanotic Congenital Heart Disease.
    Pediatr Pulmonol. 2025;60:e71141.
    >> Share

  83. URBACH H, Ostfeld-Johns S, McCollum S, Weiss P, et al
    Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71153.
    >> Share

  84. SUNMAN B, Yalcin E, Erdal MA, Sen V, et al
    Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey.
    Pediatr Pulmonol. 2025;60:e71155.
    >> Share

  85. RAJVANSHI N, Ks A, Kumar TVV
    The Inverted Steeple Sign, Tracheal Tug, and Biphasic Stridor: A Triad for Diagnosing Congenital Tracheal Stenosis.
    Pediatr Pulmonol. 2025;60:e71151.
    >> Share

  86. KAZMERSKI TM, Kidd KM, Jain R, Jathal I, et al
    Investigating the Interplay Between Having Cystic Fibrosis and Being a Member of the LGBTQIA+ Community: Protocol for the PRIDE CF Study.
    Pediatr Pulmonol. 2025;60:e71154.
    >> Share

  87. GOVER A, Smolkin T, Molad M, Lavie-Nevo K, et al
    HHHFNC Versus NIPPV Delivered by Long Narrow Cannula in Preterm Infants: Randomized Noninferiority Trial.
    Pediatr Pulmonol. 2025;60:e71167.
    >> Share

  88. SANKARARAMAN S, Prunty L, Pamer C, Thavamani A, et al
    Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase-1 in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71156.
    >> Share

  89. TRAVERS CP, Gentle SJ, Shukla VV, Aban I, et al
    Late Permissive Hypercapnia for Mechanically Ventilated Preterm Infants: A Randomized Trial.
    Pediatr Pulmonol. 2025;60:e71165.
    >> Share

  90. RIGGSBEE D, Pettit RS
    Safety of Inhaled Tobramycin for Pseudomonas Eradication in People With Cystic Fibrosis Less Than 1 Year of Age.
    Pediatr Pulmonol. 2025;60:e71162.
    >> Share

  91. XIE B, Xiang L
    An Ultra Protective Ventilation Bundle in an Infancy Severe pARDS Post Liver Transplantation.
    Pediatr Pulmonol. 2025;60:e71172.
    >> Share

  92. ALEKSANDER PE, Thee S, Doellinger F, Zagkla S, et al
    Prenatal Elexacaftor/Tezacaftor/Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71168.
    >> Share

  93. WRIGHT BA, Godfrey KC, Gryp EE, Harklau NM, et al
    Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care.
    Pediatr Pulmonol. 2025;60:e71177.
    >> Share

  94. HASEBE M, Ogawa R, Arimitsu T, Namba F, et al
    Impact of Home Oxygen Therapy for Bronchopulmonary Dysplasia on Families With Neonates: A Survey Conducted in Japan.
    Pediatr Pulmonol. 2025;60:e71179.
    >> Share

  95. FRIEDMAN D, Quittner AL, He J, Chaudhary N, et al
    Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self-Efficacy (CF-CSE) Scale.
    Pediatr Pulmonol. 2025;60:e71164.
    >> Share

  96. LYNCH J, Jensen R, Shaw M, Dumas MP, et al
    Feasibility and Utility of Multiple Breath Washout Measured Scond and Sacin in Preschool Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71180.
    >> Share

  97. HENRIKSEN EH, Sandvik RM, Olsen MF, Pressler T, et al
    Real-World Improvements of Lung Clearance Index and Ventilation Distribution Efficiency in Children With Cystic Fibrosis After Elexacaftor/Tezacaftor/Ivacaftor Initiation.
    Pediatr Pulmonol. 2025;60:e71166.
    >> Share

    May 2025
  98. HEFFERNAN ME, Barrera L, Jones M, Hayes A, et al
    The Newborn Screening Experience of Caregivers of Children With Cystic Fibrosis in the United States: A Cross-Sectional Survey.
    Pediatr Pulmonol. 2025;60:e71110.
    >> Share

  99. ARIGLIANI M, Chaudhry S, Brugha R, Suri R, et al
    Infant Lung Function in Cystic Fibrosis: A Real-World Study.
    Pediatr Pulmonol. 2025;60:e71117.
    >> Share

  100. ALBON D, Ong T, Horton B, Brighton D, et al
    Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model.
    Pediatr Pulmonol. 2025;60:e71102.
    >> Share

  101. KOCAMAN D, Yildiz CA, Metin Cakar N, Uzunoglu B, et al
    Feeding the Need: A Study on Food Security Among People With Cystic Fibrosis in Turkey.
    Pediatr Pulmonol. 2025;60:e71101.
    >> Share

  102. CAKAR MK, Uytun S, Gencoglu MY, Soydas SSA, et al
    A Rare Cause of Interstitial Lung Disease in Infancy: CCR2 Gene.
    Pediatr Pulmonol. 2025;60:e71116.
    >> Share

  103. PAL S, Ghosh M
    Risk Factors and Prediction Models for Less Invasive Surfactant Administration Failure in Preterm Infants: A Retrospective Cohort Study in a Low-and-Middle Income Country.
    Pediatr Pulmonol. 2025;60:e71127.
    >> Share

  104. STOECKLIN B, Al-Obaidi Z, Svedenkrans J, Dellaca R, et al
    Diaphragm Function in Very Preterm Infants at 36 Weeks' Postmenstrual Age.
    Pediatr Pulmonol. 2025;60:e71121.
    >> Share

  105. BARBER AT, Davis SD, Ferkol TW, Shapiro AJ, et al
    The Association of Neonatal Respiratory Distress With Ciliary Ultrastructure and Genotype in Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e71091.
    >> Share

  106. HOSHINO Y, Arai J, Hirono K, Maruo K, et al
    Impact of Sedation on Ventilator-Induced Diaphragmatic Dysfunction in Extremely Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71126.
    >> Share

  107. LEYENS J, Schroeder L, Salatsch C, Schmitt J, et al
    Flexible Bronchoscopy in Neonates With Congenital Diaphragmatic Hernia.
    Pediatr Pulmonol. 2025;60:e71128.
    >> Share

  108. DIJKMAN KP, Delbressine JJ, Dieleman JP, Mohns T, et al
    Continuous Application of Closed-Loop FiO2-Control in Extremely Preterm Infants: A Matched Cohort Single-Center Study.
    Pediatr Pulmonol. 2025;60:e71122.
    >> Share

  109. GUYOT E, Deygas F, Belhassen M, Berard M, et al
    Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France.
    Pediatr Pulmonol. 2025;60:e71134.
    >> Share

  110. RICHARD K, D'Anna R, Dahlberg SE, White H, et al
    Impact of Social Determinants on Home Oxygen Therapy Duration in Preterm Infants: A Study Utilizing the Childhood Opportunity Index.
    Pediatr Pulmonol. 2025;60:e71132.
    >> Share

  111. SAARIKALLIO S, Riikonen R, Tikkakoski A, Laitinen S, et al
    Bronchiolitis in Early Infancy Is Associated With Irreversible Airway Obstruction in Young Adulthood.
    Pediatr Pulmonol. 2025;60:e71139.
    >> Share

  112. DETAR M, Szasz B, Barta H, Szabo M, et al
    End-Tidal Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy.
    Pediatr Pulmonol. 2025;60:e71144.
    >> Share

    April 2025
  113. RUBIA-ORTEGA S, Regiroli G, Vivalda L, Loi B, et al
    Whole Body Hypothermia and Lung Aeration in Meconium Aspiration-Induced Neonatal ARDS.
    Pediatr Pulmonol. 2025;60:e71074.
    >> Share

  114. DUDOIGNON B, Bokov P, Benterki F, Couque N, et al
    Reliability of Composite Autonomic Symptom Score (COMPASS)-31 in Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2025;60:e71072.
    >> Share

  115. RAHTU M, Frerichs I, Becher TH, Pokka T, et al
    Changes in Respiratory Patterns From Pressure Control Ventilation to Neurally Adjusted Ventilatory Assist Assessed by Electrical Impedance Tomography.
    Pediatr Pulmonol. 2025;60:e71077.
    >> Share

  116. DOTAN M, Trau M, Mei-Zahav M, Mussaffi H, et al
    Pancreatic Status Is Not a Risk Factor for Cystic Fibrosis-Related Bone Disease.
    Pediatr Pulmonol. 2025;60:e71078.
    >> Share

  117. GRUBER W, Koop J, Haegele FA, Falkenberg C, et al
    Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi-Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor.
    Pediatr Pulmonol. 2025;60:e71076.
    >> Share

  118. COTE-CORRIVEAU G, Lasry A, Begin P, Bilodeau-Bertrand M, et al
    Respiratory Related Hospitalization in Children With Exposure to Meconium Aspiration or Staining.
    Pediatr Pulmonol. 2025;60:e71085.
    >> Share

  119. JOHNSON ED, Boss RD, Park WY, Aziz KB, et al
    Time Toxicity: Quantifying Healthcare Utilization Attributable to Pediatric Home Ventilation.
    Pediatr Pulmonol. 2025;60:e71081.
    >> Share

  120. ANZINGER FX, Hashagen TJ, Palaniappan P, Lindner A, et al
    Comparative Analysis of Analog and Digital Chest Tube Drainage Systems Using a High-Fidelity 3D-Printed Neonatal Chest Model.
    Pediatr Pulmonol. 2025;60:e71090.
    >> Share

  121. SINDELAR R, Ehrhardt H
    Uncovering the Physiologic Basis of Improved Oxygenation during Prone Positioning in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71086.
    >> Share

  122. BARKA K, Papachatzi E, Fouzas S, Dimitriou G, et al
    Respiratory Function in Ventilated Newborn Infants Nursed Prone and Supine.
    Pediatr Pulmonol. 2025;60:e71075.
    >> Share

  123. BANSAL M, Manimtim WM, Agarwal A, Alexiou S, et al
    Outcomes of Ventilator-Dependent Children With Severe Bronchopulmonary Dysplasia and Tracheobronchomalacia.
    Pediatr Pulmonol. 2025;60:e71100.
    >> Share

  124. FRIEDMAN D, Mullen TMD, Behrman M, Nikravan L, et al
    "How Do You Live the Best Life You Can With This Pain?" A Qualitative Study of Adults Living With CF and Pain in the Modulator ERA.
    Pediatr Pulmonol. 2025;60:e71087.
    >> Share

  125. LAEGSGAARD E, Thim SB, Holm M, Rubak S, et al
    COVID-19 in Children With Severe Lung Disease-A Tertiary Center Cohort Study in Denmark.
    Pediatr Pulmonol. 2025;60:e71094.
    >> Share

  126. MORTAMET G, Milesi C, Cassibba J, Ego A, et al
    Noninvasive Respiratory Support Weaning in Infants With Severe Bronchiolitis: High Flow Nasal Cannula May Reduce the Length of Stay.
    Pediatr Pulmonol. 2025;60:e71108.
    >> Share

  127. ABDELGHANI A, Cuneo A, Gibb E, Perito ER, et al
    Identifying Gaps and Disparities in Screening for Cystic Fibrosis Associated Liver Disease: Insights From a CF Center Analysis.
    Pediatr Pulmonol. 2025;60:e71097.
    >> Share

    March 2025
  128. VERKLEIJ M, Vlieg-Boerstra B, Hofsteenge GH, Haarman E, et al
    The Dutch Gastrointestinal Symptom Tracker for People With Cystic Fibrosis: Associations With Anxiety, Depression, and Health-Related Quality of Life.
    Pediatr Pulmonol. 2025;60:e71021.
    >> Share

  129. VAZIRI S, McGarry ME, Cuneo AA, Willen SM, et al
    A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use.
    Pediatr Pulmonol. 2025;60:e71017.
    >> Share

  130. FIREIZEN Y, Ahmed M, Vigers T, Akong K, et al
    Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71019.
    >> Share

  131. LEON C, Kawatra P, Martin A, Aoyama B, et al
    Outpatient Respiratory Outcomes in Extremely Preterm Children During the First 3 Years of Life.
    Pediatr Pulmonol. 2025;60:e71025.
    >> Share

  132. LIU W, Wei H, Xiang L, Liu Y, et al
    Bridging the Gap in Neonatal Care: Evaluating AI Chatbots for Chronic Neonatal Lung Disease and Home Oxygen Therapy Management.
    Pediatr Pulmonol. 2025;60:e71020.
    >> Share

  133. HAYDEN HS, Nelson MT, Ross SE, Verster AJ, et al
    Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71024.
    >> Share

  134. DOMANY KA, Mandelberg A, Burrack N, Golan-Tripto I, et al
    Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study.
    Pediatr Pulmonol. 2025;60:e71022.
    >> Share

  135. CLAYTON LJ, Shepherd AI, Corbett J, Gruet M, et al
    Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross-Sectional Single-Centre Study.
    Pediatr Pulmonol. 2025;60:e71044.
    >> Share

  136. HUANG L, Lai HJ, Furuya KN, Antos NJ, et al
    The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71042.
    >> Share

  137. WILLIAMS CL, Billings J, McGowan H, McDevitt R, et al
    Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71038.
    >> Share

  138. UZUNOGLU B, Selcuk Balci M, Kalyoncu M, Karabulut S, et al
    Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71037.
    >> Share

  139. MORAKEAS S, Tracy MB, Hinder M, Gruber V, et al
    Does Leak Matter? A Novel Dynamic Leak Model to Simulate Leak for Performance Testing of Manual Neonatal Resuscitation Devices. A Bench Study.
    Pediatr Pulmonol. 2025;60:e71043.
    >> Share

  140. ARPINI LDSB, Liberato FMG, Paro FM, Santos SDS, et al
    Genetic Variants and Clinical Characteristics in the Diagnosis of Children Aged Under 18 Years With Cystic Fibrosis in a Brazilian State.
    Pediatr Pulmonol. 2025;60:e71048.
    >> Share

  141. KEREM E
    Expanding the Impact of New Cystic Fibrosis Therapies in Low- and Middle-Income Countries.
    Pediatr Pulmonol. 2025;60 Suppl 1.
    >> Share

  142. COHEN-CYMBERKNOH M
    Advances in the restoration of CFTR in children and pwCF with "mild disease".
    Pediatr Pulmonol. 2025;60 Suppl 1.
    >> Share

  143. COHEN-CYMBERKNOH M
    Infection and Inflammation in the Cystic fibrosis (CF) airway.
    Pediatr Pulmonol. 2025;60 Suppl 1.
    >> Share

  144. RATJEN F
    The future of cystic fibrosis: A global perspective.
    Pediatr Pulmonol. 2025;60 Suppl 1:S75-S76.
    >> Share

  145. FORNO E
    Integrating genomics as clinical biomarkers in pediatric pulmonology.
    Pediatr Pulmonol. 2025;60 Suppl 1.
    >> Share

  146. KABRA SK
    Challenges in the care of cystic fibrosis in low-to-middle income countries.
    Pediatr Pulmonol. 2025;60 Suppl 1:S48-S50.
    >> Share

  147. RAND CM, Pelissou J, Krishnamurthi N, Chapelle XP, et al
    Congenital Central Hypoventilation Syndrome (CCHS): Patient Quality of Life and Caregiver Burden.
    Pediatr Pulmonol. 2025;60:e71012.
    >> Share

  148. SOLARSKA-RYDZ K, Marczak H, Kulus M, Krenke K, et al
    A Novel Treatment of STING-Associated Vasculopathy With Onset in Infancy.
    Pediatr Pulmonol. 2025;60:e71052.
    >> Share

    February 2025
  149. GRAPSY J, Ueng CS, Patel K, Dassner A, et al
    Initial Antibiotic Selection Based on Microbiologic History in Pediatric Cystic Fibrosis-Related Pulmonary Exacerbations.
    Pediatr Pulmonol. 2025;60:e27491.
    >> Share

  150. BALCI MS, Gokdemir Y, Eralp EE, Ergenekon AP, et al
    Implementation of Cystic Fibrosis Responsibility, Independence, Self-Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e27506.
    >> Share

  151. ILHAN O, Celik K, Ozkan NZ, Kocaoglu I, et al
    Nasal Intermittent Positive Pressure Ventilation During Neonatal Endotracheal Intubation: A Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e27512.
    >> Share

  152. KAMBARA M, Takeuchi J, Kumano A, Fujita C, et al
    Postmenstrual age at Extubation as a Risk Factor Associated With Respiratory-Related Reintubation Among Extremely Preterm Infants: A Retrospective Cohort Study.
    Pediatr Pulmonol. 2025;60:e27500.
    >> Share

  153. DUDECK B, Abebe EW, Sun W, Gaskin PR, et al
    Modifiable and Non-Modifiable Risk Factors for Tracheostomy in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71005.
    >> Share

  154. CONDIT PE, Hokanson JS, Balasubramaniam V, McCulley DJ, et al
    Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.
    Pediatr Pulmonol. 2025;60:e27501.
    >> Share

  155. GAUTAM NK, H A V, Pejaver R, Nagesh K, et al
    Diagnostic Utility of Bedside "Point of Care Lung Ultrasound" in Predicting the Need For NICU Admission in Late Preterm and Term Newborns Having Respiratory Distress Soon After Birth in the Transition Period: A Prospective Observational Study.
    Pediatr Pulmonol. 2025;60:e71000.
    >> Share

  156. SCHNEIDER-FUTSCHIK EK, Munro CB, Quinlan C, Ranganathan S, et al
    Investigating the Potential Hearing Impairment and Ototoxicity in Children up to Six Years With Cystic Fibrosis After Aminoglycoside Exposure (PIANO-CF Extension).
    Pediatr Pulmonol. 2025;60:e27505.
    >> Share

  157. FORCELLINI CA, Rossignoli S, Ficial B, Cenci G, et al
    A Refined Score, Namely Thoracic Ultrasound Score, to Predict the Need for Surfactant in Preterm Neonates: A Prospective, Multicenter, Observational Study.
    Pediatr Pulmonol. 2025;60:e71001.
    >> Share

  158. MASOLINI M, Ferrari B, Castellani C, Calogero C, et al
    Efficacy of Intrapulmonary Percussive Ventilation in a Newborn With Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e70995.
    >> Share

  159. AKKAYA A, Ilhan O, Kocaoglu I, Hakan N, et al
    Comparison of Three Methods in Estimating the Oral Endotracheal Tube Insertion Depth in Neonates: Nasal Septum-Tragus Length, Weight, or Gestation? A Randomized Trial.
    Pediatr Pulmonol. 2025;60:e70992.
    >> Share

  160. DAVIS J, Perkins R, Bailey J, Chaudary N, et al
    Acceptability of Telehealth Post-Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e70000.
    >> Share

  161. AKSOY M, Memur S, Yasa B, Cetinkaya M, et al
    A Novel and Promising Method for Prediction of Early Surfactant Requirement in Preterm Infants With Respiratory Distress Syndrome: Pulmonary Near-Infrared Spectroscopy.
    Pediatr Pulmonol. 2025;60:e71023.
    >> Share

  162. MACATANGAY NJ, Engdahl S, Pettit RS
    Tobramycin Pharmacokinetics in Pediatric Patients With Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e71018.
    >> Share

    January 2025
  163. HUANG RL, Snyder MT, Fahmida N, Albon DP, et al
    Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non-CF Bronchiectasis.
    Pediatr Pulmonol. 2025 Jan 7:e27471. doi: 10.1002/ppul.27471.
    >> Share

  164. ZWITSERLOOT AM, Aziz SZ, Chen Y, Bannier MAGE, et al
    Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real-Life Study.
    Pediatr Pulmonol. 2025;60:e27473.
    >> Share

  165. ZIRBES CF, Feder A, Pamatmat AJ, Bartels AR, et al
    Genetic Concordance of Staphylococcus aureus From Oropharyngeal and Sputum Cultures in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27475.
    >> Share

  166. MOORE PE, Hayden LP, Villafranco NM, Toprak D, et al
    Outpatient clinical care for bronchopulmonary dysplasia: A survey of the BPD collaborative.
    Pediatr Pulmonol. 2025;60:e27296.
    >> Share

  167. VERWEY C, Sojib HGK, Islam MS, Roy AD, et al
    Pulmonary Function Testing in Healthy Infants in Rural Bangladesh: Feasibility Study.
    Pediatr Pulmonol. 2025;60:e27461.
    >> Share

  168. SAPRU K, Wilkinson J, Webb AK, Akhtar M, et al
    Success Rates of Assisted Reproduction for Men With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27472.
    >> Share

  169. TERLIZZI V, Fevola C, Presti S, Claut L, et al
    Critical Issues in the Management of CRMS/CFSPID Children: A National Real-World Survey.
    Pediatr Pulmonol. 2025;60:e27483.
    >> Share

  170. PAKHATHIRATHIEN P, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Mortality Prediction in Newborns With Persistent Pulmonary Hypertension: A Comparison of Four Illness Severity Scores.
    Pediatr Pulmonol. 2025;60:e27484.
    >> Share

  171. ENOCHS C, Filbrun AG, Hjelm M, Lehrmann J, et al
    Improving implementation and team communication by integrating a cystic fibrosis transition readiness (CF R.I.S.E.) program into electronic health records.
    Pediatr Pulmonol. 2025;60:e27326.
    >> Share

  172. REYNAUD J, Dreyfus L, Coutier L, Butin M, et al
    Efficacy and tolerance of intravenous methylprednisolone pulses in children with severe bronchopulmonary dysplasia requiring respiratory support.
    Pediatr Pulmonol. 2025;60:e27344.
    >> Share

  173. ZUCKERMAN JB, Hinton AC, Lahiri T, Teneback CC, et al
    C-Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations.
    Pediatr Pulmonol. 2025;60:e27487.
    >> Share

  174. GUEDES M, Frankel D, Baron SA, Berbis J, et al
    Induced Sputum: A Valuable Tool for Assessing Cellular and Microbiological Characteristics in Cystic Fibrosis Expectorating Teenagers.
    Pediatr Pulmonol. 2025;60:e27488.
    >> Share

  175. KAM CW, McKinzie CJ, Omecene NE, Peters S, et al
    Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series.
    Pediatr Pulmonol. 2025;60:e27455.
    >> Share

  176. OZDEMIR HY, Karcioglu O, Damadoglu E, Kalyoncu AF, et al
    Evaluation of Post-Transfer Clinical Status of Cystic Fibrosis Patients Transferred to Adult Chest Diseases Clinic.
    Pediatr Pulmonol. 2025;60:e27442.
    >> Share

  177. CLARKE E, Taylor J, Watson P, Freeston J, et al
    Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life.
    Pediatr Pulmonol. 2025;60:e27418.
    >> Share

  178. KARCIOGLU O, Idikut A, Ozturk E, Damadoglu E, et al
    Outcomes of Modulator Therapy Discontinued After Short-Term Use in Adult Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27416.
    >> Share

  179. COYNE S, Condren M
    Case Report: Alpha-Gal Diagnosis in an Adolescent With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27424.
    >> Share

  180. PASLEY K, Eisner M, Sliemers S, Young R, et al
    Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor-Tezacaftor-Ivacaftor Therapy.
    Pediatr Pulmonol. 2025;60:e27393.
    >> Share

  181. OZTOSUN B, Baskan AK, Arslan H, Korkmaz C, et al
    Respiratory Outcomes of Interrupted Modulator Therapies in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27390.
    >> Share

  182. PETIT G, Coudert A, Hermann R, Truy E, et al
    Effects of Elexacaftor-Tezacaftor-Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27493.
    >> Share

  183. COLBORG A, Smith BM, Green DM, Nasr S, et al
    "It's Like You're Feeding Your Child Twice": Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27497.
    >> Share

  184. BOAT T, Hossain MM, Nakamura A, Hjelm M, et al
    Growth, Body Composition, and Strength of Children With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor (ETI).
    Pediatr Pulmonol. 2025;60:e27463.
    >> Share

  185. PETTIT RS, Sakon CM, Kinney KE, Brown C, et al
    Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27402.
    >> Share

  186. PAPADAKIS L, Stander T, Mombourquette J, Richards CJ, et al
    Heterogeneity in Reported Side Effects Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Experiences at a Quaternary CF Care Center.
    Pediatr Pulmonol. 2025;60:e27382.
    >> Share

  187. LARSEN UL, Agertoft L, Herskind AM, Strom T, et al
    Pulmonary Morbidity in Congenital Diaphragmatic Hernia Survivors Treated at a Non-ECMO Center From 1998 to 2015: A Cross-Sectional Study.
    Pediatr Pulmonol. 2025;60:e27468.
    >> Share

  188. PHALEN RF, Oldham MJ
    Observations on a Tracheobronchial Cast From a Newborn With Trisomy 13.
    Pediatr Pulmonol. 2025;60:e27456.
    >> Share

    December 2024
  189. DE FIGUEIREDO ARAUJO AG, Bastos de Souza Junior NW, de Oliveira Holanda NS, de Magalhaes FA, et al
    Prediction of Tidal Volume in Newborns Through a Novel Three-Dimensional Model: A Viability Study.
    Pediatr Pulmonol. 2024 Dec 24:e27459. doi: 10.1002/ppul.27459.
    >> Share

  190. YU D, Huang Y, Xu S, Zeng L, et al
    Evaluation of Nucleated Red Blood Cells in Peripheral Blood Increases the Predictive Value of Pediatric Critical Illness Score in Infants With Severe Pneumonia at 28 Days.
    Pediatr Pulmonol. 2024 Dec 24:e27460. doi: 10.1002/ppul.27460.
    >> Share

  191. MADDEN K, Mueller R, Brown C, Valverde KD, et al
    Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms.
    Pediatr Pulmonol. 2024 Dec 20:e27449. doi: 10.1002/ppul.27449.
    >> Share

  192. HALE L, Leyens J, Bo B, Engel C, et al
    Implementation of the Oxygen Saturation Index as a Predictor of Outcome in Prenatally Diagnosed CDH Neonates in the First 24 Hours of Life.
    Pediatr Pulmonol. 2024 Dec 17:e27447. doi: 10.1002/ppul.27447.
    >> Share

  193. MARIANI A, Ghezzi E, Pesenti N, Ophorst M, et al
    Nasal High-Flow Therapy Versus Low-Flow Oxygen Therapy Post-Discharge in Infants With Bronchopulmonary Dysplasia: A Retrospective Observational Study.
    Pediatr Pulmonol. 2024 Dec 17:e27450. doi: 10.1002/ppul.27450.
    >> Share

  194. DOZOR AJ, Vincent R
    Assessment of Phrenic Nerve Pacers in a Patient With Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2024 Dec 17:e27451. doi: 10.1002/ppul.27451.
    >> Share

  195. ARMSTRONG S, Harris C, Kazemi M, Lunt A, et al
    Labor Status at Delivery and Lung Function in Extremely Prematurely Born Young Adults.
    Pediatr Pulmonol. 2024 Dec 16:e27440. doi: 10.1002/ppul.27440.
    >> Share

  196. MCINNES E, Lock C, Harman K, Parker J, et al
    Oxygen Prescribing and Compatibility Issues in Infants Requiring Long Term Ventilation.
    Pediatr Pulmonol. 2024 Dec 13:e27408. doi: 10.1002/ppul.27408.
    >> Share

  197. ZAK SM, Onge IS, Higano NS, Bates AJ, et al
    Clinical Outcomes Through Two Years for Infants With Bronchopulmonary Dysplasia and Tracheomalacia.
    Pediatr Pulmonol. 2024 Dec 5. doi: 10.1002/ppul.27383.
    >> Share

  198. CONTE MS, Ohannesian VA, Costa Junior AS, Jacomelli M, et al
    Tumoral Form of Endobronchial Tuberculosis in an Infant With Central Nervous System Involvement.
    Pediatr Pulmonol. 2024 Dec 2:e27439. doi: 10.1002/ppul.27439.
    >> Share

  199. REISS A, Lauth W, Wald M
    Premature Infants Show Consistently Good Lung Compliance During Conventional Mechanical Ventilation.
    Pediatr Pulmonol. 2024 Dec 2:e27419. doi: 10.1002/ppul.27419.
    >> Share

  200. KORMELINK LN, Jacobs HR
    Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2024 Dec 2:e27431. doi: 10.1002/ppul.27431.
    >> Share

  201. LOPEZ CARDENES CM, Merino Sanchez-Canete A, Vicente Santamaria S, Gascon Galindo C, et al
    Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3632-3640.
    >> Share

  202. BURDIS N, Milinic T, Bartlett LE, Goss L, et al
    A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor.
    Pediatr Pulmonol. 2024;59:3641-3649.
    >> Share

  203. YILDIZ CA, Selcuk Balci M, Karabulut S, Baser ZM, et al
    Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics.
    Pediatr Pulmonol. 2024;59:3540-3549.
    >> Share

  204. CHORNEY SR, Beams DR, Nadar A, Afolabi F, et al
    Bronchopulmonary dysplasia and ventilation-associated outcomes after pediatric tracheostomy.
    Pediatr Pulmonol. 2024;59:3530-3539.
    >> Share

  205. LUO L, Li Y, Long Z, Jiang F, et al
    Exploring research trends and hotspots on oxidative stress and bronchopulmonary dysplasia: Insights from bibliometric and visualized study.
    Pediatr Pulmonol. 2024;59:3610-3623.
    >> Share

  206. PASLEY K, Dell ML, May A
    Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor.
    Pediatr Pulmonol. 2024;59:3524-3529.
    >> Share

  207. BALCI MS, Gokdemir Y, Eralp EE, Ergenekon AP, et al
    Assessment of patients' baseline cystic fibrosis knowledge levels following translation and adaptation of the CF R.I.S.E translation program into Turkish.
    Pediatr Pulmonol. 2024;59:3483-3490.
    >> Share

  208. MARZOOK N, Dubrovsky AS, Muchantef K, Zielinski D, et al
    Lung ultrasound in children with primary ciliary dyskinesia or cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3391-3399.
    >> Share

  209. FAINARDI V, Cresta F, Sorio C, Melotti P, et al
    Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations.
    Pediatr Pulmonol. 2024;59:3383-3390.
    >> Share

  210. OMECENE NE, Wilcox N, Cox AL, Ham P, et al
    A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing.
    Pediatr Pulmonol. 2024;59:3148-3158.
    >> Share

  211. MCGLYNN JR, Martin A, Aoyama BC, Bamat NA, et al
    Bronchopulmonary dysplasia and diuretic use in an outpatient setting.
    Pediatr Pulmonol. 2024;59:3426-3434.
    >> Share

  212. ROSE NR, Dabbs SG, O'Hagan EC, Guimbellot JS, et al
    Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping review.
    Pediatr Pulmonol. 2024;59:3095-3105.
    >> Share

  213. ZHENG X, Tan Z, Zhu D, Zhao D, et al
    Eclipta prostrata improves alveolar development of bronchopulmonary dysplasia via suppressing the NLRP3 inflammasome in a DLD-dependent manner.
    Pediatr Pulmonol. 2024;59:3371-3382.
    >> Share

  214. HAMIWE T, White DA, Kwenda S, Ismail A, et al
    Detection of the epidemic Pseudomonas aeruginosa AUST-03 (ST242) strain in people with cystic fibrosis in South Africa.
    Pediatr Pulmonol. 2024;59:3340-3348.
    >> Share

  215. NAYIR BUYUKSAHIN H, Yalcin E, Gokirmak I, Ertugrul G, et al
    Evaluation of otorhinolaryngologic, audiologic, and genetic findings in children with cystic fibrosis: A tertiary care experience.
    Pediatr Pulmonol. 2024;59:3298-3305.
    >> Share

  216. SWETLAND DV, Savant AP
    Cystic fibrosis year in review 2023.
    Pediatr Pulmonol. 2024;59:3106-3116.
    >> Share

  217. NIRANJAN SJ, Brown G, Bailey J, Geurs R, et al
    "I eat chocolate milk for dinner because we just have nothing in our fridge": The invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2024;59:3228-3239.
    >> Share

  218. YILDIZ CA, Selcuk Balci M, Karabulut S, Baser ZM, et al
    Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators.
    Pediatr Pulmonol. 2024;59:3250-3259.
    >> Share

  219. RILEY M, Arigliani M, Davies G, Aurora P, et al
    Looking beyond LCI: Multiple breath washout phase III slope derived indices and their application in chronic respiratory disease in children.
    Pediatr Pulmonol. 2024;59:3085-3094.
    >> Share

  220. SCHECHTER MS, Ostrenga JS, Cromwell EA, Ren CL, et al
    Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF.
    Pediatr Pulmonol. 2024;59:3212-3220.
    >> Share

  221. ALACHRAF K, Tumin D, Hayes D, Benden C, et al
    Trends in racial and ethnic disparities in pediatric lung transplantation in the United States.
    Pediatr Pulmonol. 2024;59:3204-3211.
    >> Share

  222. PALLA JB
    Disparities and therapeutic advances in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3812-3818.
    >> Share

    November 2024
  223. HAMADA K, Hirakawa E, Tanabe T, Mine T, et al
    Internal Temperature of Neonatal Endotracheal Tube Predicted by Infrared Thermography: A Neonatal Bench Study.
    Pediatr Pulmonol. 2024 Nov 29:e27425. doi: 10.1002/ppul.27425.
    >> Share

  224. HALBERT-ELLIOTT KM, Sescleifer AM, Mogayzel PJ, Kunisaki SM, et al
    Respiratory Morbidity Among Children Undergoing Surgical Resection for a Congenital Lung Malformation.
    Pediatr Pulmonol. 2024 Nov 29:e27420. doi: 10.1002/ppul.27420.
    >> Share

  225. SHEN L, Wan S, Sun X, Zheng R, et al
    Establishment and evaluation of nomogram for predicting acute respiratory distress syndrome in meconium-stained amniotic fluid neonates.
    Pediatr Pulmonol. 2024 Nov 27. doi: 10.1002/ppul.27345.
    >> Share

  226. ANDERSON MA, Masokano BI, Plummer JW, Willmering MM, et al
    Xe Ventilation and Gas-Exchange MRI Abnormalities in Children with Neuroendocrine Cell Hyperplasia of Infancy (NEHI).
    Pediatr Pulmonol. 2024 Nov 18:e27410. doi: 10.1002/ppul.27410.
    >> Share

  227. KIMOTO Y, Hirata K, Hirano S, Wada K, et al
    Post-Discharge Growth Among Extremely Preterm Infants With or Without Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2024 Nov 8. doi: 10.1002/ppul.27388.
    >> Share

  228. CRUCES P, Alcantar V, Caviedes P, Diaz F, et al
    Critical Asthma in Infancy and Toddlers: How Can We Mechanically Discriminate From Critical Bronchiolitis?
    Pediatr Pulmonol. 2024 Nov 6. doi: 10.1002/ppul.27386.
    >> Share

  229. LI J, Karabelas P, Gong L, Sheridan CA, et al
    Efficacy of a prototype inspiratory-synchronized small particle versus conventional vibrating mesh nebulizer during pediatric and neonatal mechanical ventilation.
    Pediatr Pulmonol. 2024 Nov 6. doi: 10.1002/ppul.27356.
    >> Share

  230. ZENG Y, Huang Z, Wang Y, Lin B, et al
    Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study.
    Pediatr Pulmonol. 2024 Nov 6. doi: 10.1002/ppul.27384.
    >> Share

  231. BIRO C, Muirhead C
    Nebulized granulocyte macrophage-colony stimulating factor to stabilize lung function in nontuberculous mycobacteria pulmonary disease in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3001-3003.
    >> Share

  232. EMIRALIOGLU N, Cakir B, Sertcelik A, Yalcin E, et al
    Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study.
    Pediatr Pulmonol. 2024;59:2956-2966.
    >> Share

  233. MEDBO J, Imberg H, Hansen C, Krantz C, et al
    Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study.
    Pediatr Pulmonol. 2024;59:2967-2975.
    >> Share

  234. GEORGIOPOULOS AM, DiFiglia S, Seng EK, Portenoy R, et al
    Validation of the Integrated Palliative Care Outcome Scale (IPOS) in adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2857-2866.
    >> Share

  235. VIDAURRETA S, Desantadina V, Galizzi M
    Idiopathic intracranial hypertension in a pediatric patient with cystic fibrosis on ETI generic formulation treatment.
    Pediatr Pulmonol. 2024;59:3009-3011.
    >> Share

  236. RAIMONDI F
    Tailored surfactant replacement requires accurate evaluation of multiple factors.
    Pediatr Pulmonol. 2024;59:2731.
    >> Share

  237. LEON C, Martin A, Young LR, Aoyama BC, et al
    Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:2815-2822.
    >> Share

  238. DACCO V, Rosazza C, Mariani A, Rizza C, et al
    Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting.
    Pediatr Pulmonol. 2024;59:2792-2799.
    >> Share

  239. DOWLE H, Unger S, Khalid S, Brown C, et al
    Reversible deafness related to long-term daily Azithromycin treatment in a child with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2990-2992.
    >> Share

    October 2024
  240. GILLESPIE ML, Jayaram S, Eisner M, Sliemers S, et al
    Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis.
    Pediatr Pulmonol. 2024 Oct 29. doi: 10.1002/ppul.27364.
    >> Share

  241. YE D, Yuan T, Jiang M
    Langerhans cell histiocytosis in an infant.
    Pediatr Pulmonol. 2024 Oct 28. doi: 10.1002/ppul.27352.
    >> Share

  242. TESTA I, Muthialu N, Beeman A, Aurora P, et al
    Congenital lobar overinflation, from antenatal diagnosis to long-term follow-up: A single-center experience.
    Pediatr Pulmonol. 2024 Oct 25. doi: 10.1002/ppul.27346.
    >> Share

  243. GARCIA-ANTON A, Dreyfus L, Portefaix A, Baudin F, et al
    Factors of late respiratory support or oxygen weaning in infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Oct 25. doi: 10.1002/ppul.27367.
    >> Share

  244. RUBINACCI V, Martinelli S, Proto A, Vitelli O, et al
    Necrotizing pneumonia in a preterm baby.
    Pediatr Pulmonol. 2024 Oct 23. doi: 10.1002/ppul.27350.
    >> Share

  245. LIZ CF, Proenca E
    Oxygen in the newborn pneriod: Could the oxygen reserve index offer a new perspective?
    Pediatr Pulmonol. 2024 Oct 22. doi: 10.1002/ppul.27343.
    >> Share

  246. BRISKI K, Murphy B, Diaz D, Parrott A, et al
    Atypical presentation of primary lung abscess in an infant.
    Pediatr Pulmonol. 2024 Oct 14. doi: 10.1002/ppul.27324.
    >> Share

  247. NASCIMENTO MS, Khemani RG, Newth CJL
    Challenges in using the ROX index as a predictor of failure in high flow nasal cannula in infants with respiratory failure.
    Pediatr Pulmonol. 2024 Oct 14. doi: 10.1002/ppul.27332.
    >> Share

  248. STEIN ES, Hevroni A, Zarfati M, Erlichman I, et al
    Comprehensive pulmonary function analysis identifies predominant obstructive phenotype in former premature infants around one year of age.
    Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27287.
    >> Share

  249. TSOI SM, Keller RL
    Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology-Response.
    Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27312.
    >> Share

  250. PIJNENBURG MW
    Long-term respiratory consequences of prematurity.
    Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27304.
    >> Share

  251. PHAM H, Vandeleur M, Mainzer RM, Ranganathan S, et al
    Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2606-2613.
    >> Share

  252. LEE JX, Ryan M, Mukharesh L, Dahlberg SE, et al
    Comparison of home-based spirometry and oscillometry measurements in school-age children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:2589-2596.
    >> Share

  253. HUANG J, Xing G, Kong X
    Lower peripheral blood CD4(+) lymphocyte ratio is associated with severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:2580-2588.
    >> Share

  254. GOOD A, Shannon J, Brinton JT, Hoppe JE, et al
    Implementation and outcomes of a quality improvement project to systematically assess the gross motor skills in school-aged children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2597-2605.
    >> Share

  255. NAYIR BUYUKSAHIN H, Emiralioglu N, Yalcin E, Sen V, et al
    Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators.
    Pediatr Pulmonol. 2024;59:2499-2506.
    >> Share

  256. SHAKKOTTAI A, Kim S, Mitchell RB
    Obstructive sleep apnea in children with cystic fibrosis on highly effective modulator therapy.
    Pediatr Pulmonol. 2024;59:2535-2542.
    >> Share

  257. KUMAR S, Pallin M, Soldatos G
    Codevelopment of a model of care for adults living with cystic fibrosis-related diabetes.
    Pediatr Pulmonol. 2024;59:2472-2481.
    >> Share

  258. REN CL, Nasr SZ, Slaven JE, Joshi A, et al
    Lung T1 MRI assessments in children with mild cystic fibrosis lung disease.
    Pediatr Pulmonol. 2024;59:2464-2471.
    >> Share

    September 2024
  259. KUGELMAN A
    Striving for healthy lungs: Enhancing respiratory outcomes of prematurity.
    Pediatr Pulmonol. 2024 Sep 30. doi: 10.1002/ppul.27309.
    >> Share

  260. KUITUNEN I, Rannankari M, Rasanen K
    Neurally adjusted ventilatory assist (NAVA) in neonatal and pediatric critical care-A scoping review of randomized controlled trials.
    Pediatr Pulmonol. 2024 Sep 27. doi: 10.1002/ppul.27293.
    >> Share

  261. MERINO-MATEO L, Morante R, Lopez M, Jimenez I, et al
    Congenital laryngeal cysts mimicking laryngomalacia.
    Pediatr Pulmonol. 2024 Sep 27. doi: 10.1002/ppul.27298.
    >> Share

  262. PHAN PH, Tran HMT, Hoang CN, Nguyen TV, et al
    The epidemiology of critical respiratory diseases in ex-premature infants in Vietnam: A prospective single-center study.
    Pediatr Pulmonol. 2024 Sep 25. doi: 10.1002/ppul.27289.
    >> Share

  263. GOUSSARD P, van Wyk L, Gie A, Jacobs C, et al
    Severe airway obstruction due to pulmonary tuberculosis in a premature infant needing decompression of mediastinal lymph nodes.
    Pediatr Pulmonol. 2024 Sep 24. doi: 10.1002/ppul.27282.
    >> Share

  264. BURATTI CR, Andreolio C, Bruno F, Andrade LB, et al
    Peak inspiratory pressure lacks accuracy to estimate plateau pressure in infants with severe obstructive lower airway disease.
    Pediatr Pulmonol. 2024 Sep 19. doi: 10.1002/ppul.27245.
    >> Share

  265. NGUYEN TA, Matousek J, Kubena A, Resl K, et al
    Ventilator variables predicting extubation readiness in extremely premature infants with prolonged mechanical ventilation: A retrospective observational study.
    Pediatr Pulmonol. 2024 Sep 12. doi: 10.1002/ppul.27265.
    >> Share

  266. MOLNAR Z, van Leuteren RW, Wilinka M, Szczapa T, et al
    Performance and safety of volume guarantee ventilation in neonates using the fabian ventilator, a multicenter study.
    Pediatr Pulmonol. 2024 Sep 12. doi: 10.1002/ppul.27264.
    >> Share

  267. BUSH A
    Interstitial lung disease in infancy and early childhood: Clinical approach.
    Pediatr Pulmonol. 2024 Sep 11. doi: 10.1002/ppul.27254.
    >> Share

  268. WANG L, Chen L, Liu H
    Recurrent dyspnea caused by congenital lobar emphysema in a premature child.
    Pediatr Pulmonol. 2024 Sep 10. doi: 10.1002/ppul.27252.
    >> Share

  269. VADYALA M, Tanneru S, Vadije PR, Murki S, et al
    A quality improvement initiative for reducing respiratory care costs in neonates admitted to a tertiary-level NICU in India.
    Pediatr Pulmonol. 2024 Sep 2. doi: 10.1002/ppul.27243.
    >> Share

  270. SAIKUMAR P, Sadauskas M, Izhar S, Moshiree B, et al
    Constipation and DIOS: Diagnosis, differential diagnosis, and management.
    Pediatr Pulmonol. 2024;59 Suppl 1:S81-S90.
    >> Share

  271. RAMSEY ML, Galante GJ
    Pancreas and pancreatitis: Exocrine pancreatic insufficiency.
    Pediatr Pulmonol. 2024;59 Suppl 1:S44-S52.
    >> Share

  272. JOBANPUTRA AM, Kesavarapu K, Naik S, Ramagopal M, et al
    Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea.
    Pediatr Pulmonol. 2024;59 Suppl 1:S27-S35.
    >> Share

  273. GREEN N, Chan C, Ooi CY
    The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis.
    Pediatr Pulmonol. 2024;59 Suppl 1:S70-S80.
    >> Share

  274. PALLE SK, Leung DH
    Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations.
    Pediatr Pulmonol. 2024;59 Suppl 1:S115-S122.
    >> Share

  275. LYONS ER, Muther E, Sabharwal S
    Nutrition and behavioral health in cystic fibrosis: Eating and body image.
    Pediatr Pulmonol. 2024;59 Suppl 1:S36-S43.
    >> Share

  276. KASPER VL, Assis DN
    Pathophysiology of Cystic Fibrosis Liver Disease.
    Pediatr Pulmonol. 2024;59 Suppl 1:S98-S106.
    >> Share

  277. BASS R, Alvarez JA
    Nutritional status in the era of highly effective CFTR modulators.
    Pediatr Pulmonol. 2024;59 Suppl 1:S6-S16.
    >> Share

  278. SANKARARAMAN S, Freeman AJ
    Early detection of hepatobiliary involvement in cystic fibrosis: Biomarkers, radiologic methods, and genetic influences.
    Pediatr Pulmonol. 2024;59 Suppl 1:S107-S114.
    >> Share

  279. RAZA Z, Islam BN, Hachem CY, Cummings LC, et al
    Evolving data on risk and current screening recommendations for colorectal cancer in cystic fibrosis: Pre- and posttransplant.
    Pediatr Pulmonol. 2024;59 Suppl 1:S91-S97.
    >> Share

  280. GABEL ME, Gaudio RE, Shaikhkhalil AK
    Improving growth in infants with CF.
    Pediatr Pulmonol. 2024;59 Suppl 1:S17-S26.
    >> Share

  281. VELEZ C, Neuringer I, Schwarzenberg SJ
    The foregut in cystic fibrosis.
    Pediatr Pulmonol. 2024;59 Suppl 1:S61-S69.
    >> Share

  282. MILANO RV, Morneault-Gill K, Kamal HY, Barkin JA, et al
    Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies.
    Pediatr Pulmonol. 2024;59 Suppl 1:S53-S60.
    >> Share

  283. SATHE M, Stein A
    Remaining barriers to normalcy in cystic fibrosis: Considerations in GI, liver, and nutrition.
    Pediatr Pulmonol. 2024;59 Suppl 1:S5.
    >> Share

    August 2024
  284. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    Social determinants of health and somatic growth in preterm infants and children with chronic lung disease.
    Pediatr Pulmonol. 2024 Aug 30. doi: 10.1002/ppul.27237.
    >> Share

  285. DERMITZAKI N, Chatzigiannis N, Baltogianni M, Kamperi ME, et al
    Atypical presentation and management of a neonate with alveolar capillary dysplasia: A case report.
    Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27241.
    >> Share

  286. LUO K, Tang J, Chen H, Zhang X, et al
    Vasodilators for persistent pulmonary hypertension of the newborn: A network meta-analysis.
    Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27234.
    >> Share

  287. MOKHA SA, Lakshminrusimha S
    Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology.
    Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27227.
    >> Share

  288. MADHUSUDAN M, Mohite K, Chandra T, Potti P, et al
    A dual endoscopic approach for a recurrent congenital tracheoesophageal fistula.
    Pediatr Pulmonol. 2024 Aug 27. doi: 10.1002/ppul.27230.
    >> Share

  289. LIANG GB, Wang L, Huang SQ, Yao ML, et al
    A multicenter epidemiological survey of iNO use in preterm infants in China.
    Pediatr Pulmonol. 2024 Aug 27. doi: 10.1002/ppul.27228.
    >> Share

  290. LI B, Qu SS, Li LX, Zhou N, et al
    Risk factors and clinical outcomes of pulmonary hypertension associated with bronchopulmonary dysplasia in extremely premature infants: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2024 Aug 23. doi: 10.1002/ppul.27220.
    >> Share

  291. MONTAGNA S, Magno D, Ferretti S, Stelluti M, et al
    Combining artificial intelligence and conventional statistics to predict bronchopulmonary dysplasia in very preterm infants using routinely collected clinical variables.
    Pediatr Pulmonol. 2024 Aug 16. doi: 10.1002/ppul.27216.
    >> Share

  292. MICAELLI D, Ghelab Z, Delclaux C, Artu-Dumont C, et al
    Education program for caregivers in congenital central hypoventilation syndrome: Initiation and experience families.
    Pediatr Pulmonol. 2024 Aug 16. doi: 10.1002/ppul.27217.
    >> Share

  293. DOSSCHE LWJ, van den Aardwegh CS, Kersten CM, van Rosmalen J, et al
    Postnatal chest X-ray in children with asymptomatic congenital lung malformations.
    Pediatr Pulmonol. 2024 Aug 7. doi: 10.1002/ppul.27201.
    >> Share

    July 2024
  294. WYLER F, Manogaran T, Monney N, Salem Y, et al
    Optimized algorithm for speed-of-sound-based infant sulfur hexafluoride multiple-breath washout measurements.
    Pediatr Pulmonol. 2024 Jul 18. doi: 10.1002/ppul.27180.
    >> Share

  295. MENEGOLLA MP, Silveira RC, Gorgen ARH, Gandolfi FE, et al
    Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants.
    Pediatr Pulmonol. 2024 Jul 18. doi: 10.1002/ppul.27182.
    >> Share

  296. CHOUDHARY S, Muise ED, Hammouda S, Goetz D, et al
    New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR-related metabolic syndrome.
    Pediatr Pulmonol. 2024 Jul 11. doi: 10.1002/ppul.27160.
    >> Share

  297. SANCHEZ-SOLIS M, Forno E, Morales E, Garcia-Marcos L, et al
    Role of body mass index in unbalanced (dysanaptic) lung growth of healthy infants.
    Pediatr Pulmonol. 2024 Jul 5. doi: 10.1002/ppul.27161.
    >> Share

  298. CANELLA R, Feld L, Balmer D, Franklin M, et al
    Using a longitudinal qualitative approach to understand the lived experiences of caregivers of infants with obstructive sleep apnea who require chronic noninvasive respiratory support.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27107.
    >> Share

  299. BROKKEN T, Hutten MC, Ophelders DRMG, van Gorp C, et al
    Optimized lung expansion ventilation modulates ventilation-induced lung injury in preterm lambs.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27153.
    >> Share

  300. NELIN TD, Radack JK, Yang N, Lorch SA, et al
    Associations of PM(2.5) exposure with emergency department visits and readmissions among preterm infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27164.
    >> Share

  301. MERINO-HERNANDEZ A, Munoz-Cutillas A, Ramos-Navarro C, Bellon-Alonso S, et al
    Long-term lung function follow-up of preterm infants less than 32 weeks of gestational age.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27158.
    >> Share

  302. FICIAL B, Dolce P, Petoello E, Flore AI, et al
    Left atrial strain assessment unveils left ventricular diastolic dysfunction in neonates with transient tachypnea of the newborn: A prospective observational study.
    Pediatr Pulmonol. 2024 Jul 2. doi: 10.1002/ppul.27156.
    >> Share

  303. DE WAAL K
    "Wet lung" of the newborn: Respiratory signs and symptoms caused by cardiac physiology?
    Pediatr Pulmonol. 2024 Jul 2. doi: 10.1002/ppul.27168.
    >> Share

  304. DE OLIVEIRA TJ, Altoe ID, Arpini LDSB, Liberato FMG, et al
    Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID-19 pandemic: A 24-month cohort study.
    Pediatr Pulmonol. 2024;59:1962-1969.
    >> Share

  305. ELIDOTTIR H, Bjarnadottir SR, Baldursson O, Jonsdottir B, et al
    Cystic fibrosis in Iceland and the high prevalence of the N1303K variant.
    Pediatr Pulmonol. 2024;59:1944-1951.
    >> Share

  306. DE VUYST R, Kam CW, McKinzie CJ, Esther CR, et al
    Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor.
    Pediatr Pulmonol. 2024;59:2051-2054.
    >> Share

  307. SCHUMACHER S, Harklau NM, Osterhaus JK, Wright BA, et al
    Overweight, understudied: The new need for weight loss modalities in CF patients.
    Pediatr Pulmonol. 2024;59:2021-2023.
    >> Share

  308. MITCHELL E, Albon D
    Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants.
    Pediatr Pulmonol. 2024;59:2009-2011.
    >> Share

  309. WEINBERGER M, Buettner D
    Commentary addressing concerns raised by Dr. Slovarp and her colleagues.
    Pediatr Pulmonol. 2024;59:1851-1853.
    >> Share

    June 2024
  310. MCGARRY ME, Sciortino S, Graham S, Bishop T, et al
    Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
    Pediatr Pulmonol. 2024 Jun 28. doi: 10.1002/ppul.27155.
    >> Share

  311. MARCZAK H, Peradzynska J, Paplinska-Goryca M, Misiukiewicz-Stepien P, et al
    Serum biomarkers in neuroendocrine cell hyperplasia of infancy.
    Pediatr Pulmonol. 2024 Jun 27. doi: 10.1002/ppul.27148.
    >> Share

  312. WRIGHT M, Knowles RL, Cortina-Borja M, Javadpour S, et al
    Airway management in infants with Robin sequence in the United Kingdom and Ireland: A prospective population-based study.
    Pediatr Pulmonol. 2024 Jun 21. doi: 10.1002/ppul.27140.
    >> Share

  313. WACHSMUTH L, Bieli C, Grehten P, Moehrlen T, et al
    Sleep-disordered breathing on respiratory polygraphy in neonates with spina bifida.
    Pediatr Pulmonol. 2024 Jun 18. doi: 10.1002/ppul.27137.
    >> Share

  314. JI F, Gu X, Bao Y, Zhang Q, et al
    Association between Ureaplasma colonization and bronchopulmonary dysplasia defined by different criteria in very low birth weight infants: A retrospective cohort study.
    Pediatr Pulmonol. 2024 Jun 14. doi: 10.1002/ppul.27121.
    >> Share

  315. GURBANI N, Ehsan Z, Boh M, Schuler CL, et al
    Comparison of high flow nasal cannula therapy to nasal oxygen as a treatment for obstructive sleep apnea in infants.
    Pediatr Pulmonol. 2024 Jun 5. doi: 10.1002/ppul.27109.
    >> Share

  316. MIRAFTABI P, Kirjavainen T, Lohi J, Martelius L, et al
    The original histopathologic description of neuroendocrine cell hyperplasia of infancy is not applicable to every patient with the disease.
    Pediatr Pulmonol. 2024 Jun 5. doi: 10.1002/ppul.27118.
    >> Share

  317. STEWART KL, Szczesniak R, Liou TG
    Predicting weight gain in patients with cystic fibrosis on triple combination modulator.
    Pediatr Pulmonol. 2024;59:1724-1730.
    >> Share

  318. GUO J, King I, Hill A
    International disparities in diagnosis and treatment access for cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1622-1630.
    >> Share

  319. WYATT ML, Sokolow AG, Brown RF, Kaslow JA, et al
    Prevalence, stability, and clinical significance of an isolated low FEV(1) spirometry pattern in children.
    Pediatr Pulmonol. 2024;59:1747-1756.
    >> Share

  320. BATHGATE JR, Pike K, Newkirk M, Rigassio Radler DL, et al
    Development of a bronchopulmonary dysplasia nutrition focused physical examination tool: A modified Delphi study.
    Pediatr Pulmonol. 2024;59:1695-1707.
    >> Share

  321. CUNEO A, Smith-Thomas T, Marsac M
    Opportunities for trauma-informed medical care in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1814-1816.
    >> Share

  322. MCKINZIE CJ, Kam CW, Jones MC, Gifford LB, et al
    Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1795-1797.
    >> Share

  323. KUMAR M, Aaron R, Varkki SD, Danda S, et al
    A rare variant c.1802T>C (p. Ile601Thr) associated with severe phenotype among people with cystic fibrosis from south India, and potential genetic admixture in Reunion, France.
    Pediatr Pulmonol. 2024;59:1820-1825.
    >> Share

  324. SHERWOOD SJ, Tak C, Bhakta ZN, Packer K, et al
    A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1740-1746.
    >> Share

  325. BERLIN KEK, Lagatta J, Dawson S, Malnory M, et al
    Inpatient education reduces length of outpatient oxygen therapy in bronchopulmonary dysplasia: A quality improvement project.
    Pediatr Pulmonol. 2024;59:1677-1685.
    >> Share

  326. CARROLL BJ, Ostrenga JS, Fink AK, Antos NJ, et al
    Clinical outcomes at 9-10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome.
    Pediatr Pulmonol. 2024;59:1606-1613.
    >> Share

  327. LANDESS L, Prieur MG, Brown AR, Dellon EP, et al
    Exploring perceptions of and decision-making about CFTR modulators.
    Pediatr Pulmonol. 2024;59:1614-1621.
    >> Share

  328. AGARWAL A, McKinney RL, Baker CD, Nelin LD, et al
    Adapting to changing ventilator access: Impact on management of severe bronchopulmonary dysplasia in children.
    Pediatr Pulmonol. 2024;59:1803-1806.
    >> Share

  329. O'DONNELL JEM, Hastings LA, Briody JN, Chan CL, et al
    SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium.
    Pediatr Pulmonol. 2024;59:1661-1676.
    >> Share

    May 2024
  330. GRIESE M, Seidl E
    Persistent tachypnea of infancy, neuroendocrine cell hyperplasia of infancy, and pulmonary interstitial glycogenosis: "A3-Specific conditions of undefined etiology".
    Pediatr Pulmonol. 2024 May 31. doi: 10.1002/ppul.27102.
    >> Share

  331. SCHMIDT HP, Paskaradevan J
    Anomalous systemic venous return: An extremely rare cause of hypoxemia in a neonate.
    Pediatr Pulmonol. 2024 May 27. doi: 10.1002/ppul.27074.
    >> Share

  332. DOSSCHE L, Kersten C, van Rosmalen J, Wijnen R, et al
    Lower respiratory tract infections in children with congenital lung abnormalities.
    Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27067.
    >> Share

  333. CHEN C, Jin Y, Jin H, Chen S, et al
    Adipose mesenchymal stem cells-derived exosomes attenuated hyperoxia-induced lung injury in neonatal rats via inhibiting the NF-kappaB signaling pathway.
    Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27057.
    >> Share

  334. NOBILE S, Catalano P, Perri A, Lio A, et al
    Lung agenesis in a preterm infant: Lung function test findings in the first 2 years of life.
    Pediatr Pulmonol. 2024 May 15. doi: 10.1002/ppul.27042.
    >> Share

  335. MANIACI J, Kearney MD, DeMauro SB, Panitch H, et al
    Lived experiences of caregivers with infants treated at home with continuous invasive or noninvasive ventilation.
    Pediatr Pulmonol. 2024 May 15. doi: 10.1002/ppul.27063.
    >> Share

  336. RAO T, Zhou Y, Chen C, Chen J, et al
    Recent progress in neonatal hyperoxic lung injury.
    Pediatr Pulmonol. 2024 May 14. doi: 10.1002/ppul.27062.
    >> Share

  337. SANCHEZ-FERRER F, Nso-Roca AP
    Unusually severe neonatal presentation of mediastinal bronchogenic cyst.
    Pediatr Pulmonol. 2024 May 14. doi: 10.1002/ppul.27048.
    >> Share

  338. DE MEDEIROS CAVALCANTE MENEGHE, Aragon DC, Calixto C, Ferreira CHF, et al
    Personalized lung care: Bronchopulmonary dysplasia risk prediction tool tailored for neonates born in resource-limited settings.
    Pediatr Pulmonol. 2024 May 7. doi: 10.1002/ppul.27049.
    >> Share

  339. BULLON-GONZALEZ I, Cabeza-Arce N, Andres-Porras P, Ferrer-Ortiz I, et al
    Lessons from Covid: Effect of community mask use on infant hospitalizations for respiratory infections.
    Pediatr Pulmonol. 2024 May 7. doi: 10.1002/ppul.27043.
    >> Share

  340. WU YH, Hsiao CH, Chen YL, Tsai LY, et al
    Rare type of tracheal agenesis: Unexpected presentation and immediate consideration of emergent esophageal intubation in neonatal resuscitation program. Case reports and review of the literature.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.26990.
    >> Share

  341. KAY DM, Sadeghi H, Kier C, Berdella M, et al
    Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27023.
    >> Share

  342. JIMENEZ-NOGUEIRA E, Bueno-Rebollo C, Garcia-Jerez B, Callejon-Fernandez E, et al
    Impact of breastfeeding on ICU admissions and need for mechanical ventilation in infants younger than 6 months with RSV+ bronchiolitis. An observational study.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27036.
    >> Share

  343. URQUHART DS, Dowle H, Moffat K, Forster J, et al
    Lung clearance index (LCI(2.5)) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data.
    Pediatr Pulmonol. 2024;59:1449-1453.
    >> Share

  344. YOUSIF D, Cerini C, Ward S, Iyer N, et al
    Retrospective study of serial polysomnograms of bronchopulmonary dysplasia patients with oxygen dependence.
    Pediatr Pulmonol. 2024;59:1418-1427.
    >> Share

  345. BENDOUKHA I, Boucherit-Otmani Z, Baba Ahmed-Kazi Tani ZZ, Seghir A, et al
    Initial characteristics of cystic fibrosis in Algeria: Description of 34 pediatric cases.
    Pediatr Pulmonol. 2024;59:1454-1461.
    >> Share

  346. HARRIGAN M, Jessup M, Bennett K, Mulrennan S, et al
    Me, myself, and I: A systematic review of cystic fibrosis and self-concept.
    Pediatr Pulmonol. 2024;59:1175-1195.
    >> Share

  347. GAMBAZZA S, Mariani A, Guarise R, Ferrari B, et al
    Short-term effects of positive expiratory pressure mask on ventilation inhomogeneity in children with cystic fibrosis: A randomized, sham-controlled crossover study.
    Pediatr Pulmonol. 2024;59:1354-1363.
    >> Share

  348. WRIGHT BA, De Andrade LM, Dumitrescu AV, Larson SA, et al
    A new vision: Integration of ophthalmology services into an interdisciplinary pediatric cystic fibrosis clinic model.
    Pediatr Pulmonol. 2024;59:1502-1504.
    >> Share

  349. ATTEIH SE, Armbruster CR, Hilliam Y, Rapsinski GJ, et al
    Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1266-1273.
    >> Share

  350. POULSEN M, Holland AE, Button B, Jones AW, et al
    Preferences and perspectives regarding telehealth exercise interventions for adults with cystic fibrosis: A qualitative study.
    Pediatr Pulmonol. 2024;59:1217-1226.
    >> Share

    April 2024
  351. ARADHYA AS, Ghalige SS, Madarkar B, Pruthvishree HV, et al
    Comparison of porcine versus bovine surfactant in preterm respiratory distress syndrome: Evidence from real-world data. A multicentre collaboration from Karnataka.
    Pediatr Pulmonol. 2024 Apr 25. doi: 10.1002/ppul.27032.
    >> Share

  352. TSOU PY, Tapia IE
    Tracheostomy and inpatient outcomes among children with congenital central hypoventilation syndrome: A kids' inpatient database study.
    Pediatr Pulmonol. 2024 Apr 17. doi: 10.1002/ppul.27015.
    >> Share

  353. LOHMANN P, Hagan JL, Fernandes CJ
    A breath of fresh air: Does spontaneous breathing and early repair in neonates with very mild congenital diaphragmatic hernia lead to earlier discharge?
    Pediatr Pulmonol. 2024 Apr 17. doi: 10.1002/ppul.27003.
    >> Share

  354. LEFEVERE J, van Delft B, Decaluwe W, Derriks F, et al
    Neurally adjusted ventilatory assist in preterm infants: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2024 Apr 3. doi: 10.1002/ppul.27001.
    >> Share

  355. DUDOIGNON B, Khirani S, Vedrenne-Cloquet M, Amaddeo A, et al
    Work of breathing: A tool for the respiratory management of severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:1128-1132.
    >> Share

  356. TAMER G, Arets HGM, van der Ent CK, van Santen HM, et al
    BMI increase during early childhood in boys with cystic fibrosis and early adrenarche.
    Pediatr Pulmonol. 2024;59:991-996.
    >> Share

  357. VAZIRI S, McGarry ME, Huang CY, Cuneo AA, et al
    Time to be blunt: Substance use in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1015-1027.
    >> Share

  358. WELSNER M, Gruber W, Blosch C, Olivier M, et al
    Impact of habitual physical activity and exercise capacity on quality of life in adolescents and adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:949-963.
    >> Share

  359. ZAFAR A, Hall M
    Types of home respiratory support in children with bronchopulmonary dysplasia and factors determining its duration: A scoping review.
    Pediatr Pulmonol. 2024;59:834-844.
    >> Share

  360. POWER HA, Shivak SM, Kim J, Wright KD, et al
    A systematic review of attention-deficit/hyperactivity disorder in people living with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:825-833.
    >> Share

  361. ZWITSERLOOT AM, Verhoog FA, van den Berge M, Gappa M, et al
    Comparison of particles in exhaled air and multiple breath washout for assessment of small airway function in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:915-922.
    >> Share

  362. PATEL N, Ansar M, Pham A, Thomsen K, et al
    Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:863-866.
    >> Share

  363. MAYNARD R, Armstrong M, O'Grady K, Moore B, et al
    Predischarge death or lung transplantation in tracheostomy and ventilator dependent grade 3 bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:867-873.
    >> Share

  364. SUBRAMANIAN P, Singhal M, Sharma A
    Unique segmental branching of right pulmonary artery in association with patent ductus arteriosus and anomalous carotid origin of left vertebral artery.
    Pediatr Pulmonol. 2024;59:1092-1094.
    >> Share

    March 2024
  365. LEON-ASTUDILLO C, Dy FJ, McCown MY, Perez IA, et al
    ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants.
    Pediatr Pulmonol. 2024 Mar 28. doi: 10.1002/ppul.26961.
    >> Share

  366. MIZOGAMI M, Hasegawa H, Yamada Y, Wasa M, et al
    Examination of changes in the breathing intolerance index to determine the respiratory support needs of very low birth weight infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26969.
    >> Share

  367. DE QUEIROZ ANDRADE E, Sena CRDS, de Gouveia Belinelo P, Robinson PD, et al
    In utero smoking exposure induces changes to lung clearance index and modifies risk of wheeze in infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26975.
    >> Share

  368. TARRELL A, Grinsell M, Lewis KW, Yoder BA, et al
    Bronchopulmonary dysplasia severity and bone status in preterm infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26967.
    >> Share

  369. NOUR BA, El-Rahman AMA, Hameed SAEAE, Mohsen N, et al
    Lung and diaphragm ultrasound as predictors of successful weaning from nasal continuous positive airway pressure in preterm infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26933.
    >> Share

  370. PERRI A, Prontera G, Fattore S, Sbordone A, et al
    Tracheal bronchus related symptoms in a premature neonate: The role of lung ultrasound in the management of this condition.
    Pediatr Pulmonol. 2024 Mar 5. doi: 10.1002/ppul.26944.
    >> Share

  371. DANI C, Miselli F, Zini T, Scarponi D, et al
    Measurement of lung oxygenation by near-infrared spectroscopy in preterm infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Mar 5. doi: 10.1002/ppul.26955.
    >> Share

  372. KIER C, Kay DM, Langfelder-Schwind E, Goetz DM, et al
    Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State.
    Pediatr Pulmonol. 2024 Mar 1. doi: 10.1002/ppul.26928.
    >> Share

    January 2024
  373. DANI C, Napolitano M, Barone C, Manna A, et al
    Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
    Pediatr Pulmonol. 2024 Jan 22. doi: 10.1002/ppul.26879.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016